Biohaven revealed in a filing with the Securities and Exchange Commission (SEC) that it has been updated on the progress of ...

The SPDR Select Sector Health Care exchange-traded fund, which tracks the health-care industry group of the S&P 500, rose 0.8% on Friday, and is only marginally in the green for the year to date, ...

Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit.

Biohaven stock surged early Friday after the FDA canceled an upcoming meeting to discuss the benefits and risks of its drug, ...

Analysts found the agency's decision to cancel the meeting encouraging. Elsewhere, the Novo Holdings-owned CDMO cut about 350 ...

Biohaven Ltd. (NYSE:BHVN) stock is trading higher on Friday following an update with respect to its New Drug Application for ...

Biohaven in May reported that the FDA had extended its review of the new-drug application for troriluzole by three months after the New Haven, Conn., company submitted additional information, and said ...

Biohaven (NYSE:BHVN) stock gains as the FDA cancels an advisory meeting scheduled to review its marketing application for ...

The latest announcement is out from Biohaven Ltd. ( (BHVN) ).

Investing.com -- Biohaven Ltd. (NYSE: BHVN) stock rose 3% Friday morning after the company announced that the U.S. Food and Drug Administration (FDA) no longer plans to hold an advisory committee ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, both dates inclusiv ...